LAHO - Lans Holdings, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0015
+0.0001 (+7.14%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.0014
Open0.0013
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0013 - 0.0017
52 Week Range0.0000 - 0.0018
Volume146,610,098
Avg. Volume269,372,693
Market Cap363,432
Beta (3Y Monthly)-10.79
PE Ratio (TTM)N/A
EPS (TTM)-0.1790
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group

    MIAMI, FL, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Lans Holdings Inc. is pleased to announce that it has successfully completed its due diligence as per the binding letter of intent to acquire 100% of Global Stem Cells Group Inc (GSCG). The company has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status. The Company makes it easy for sellers to start selling, and buyers to buy with confidence.

  • GlobeNewswire

    LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers

    Miami, FL, June 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Lans Holdings Inc. is pleased to announce that Global Stem Cells Group Inc. (GSCG) www.stemcellsgroup.com has opened two new stem cell offices, one in Valencia, Spain and one in Cochabamba, Bolivia. This brings the total number of global Stem Cell centers to 36 worldwide in 27 countries. The new clinic in Valencia will be the group’s third operation in Spain and the fourth in Europe.

  • GlobeNewswire

    Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group

    MIAMI, FL, May 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –  Lans Holdings Inc. (LAHO) is pleased to announce that it has entered into a binding letter of intent to acquire 100% of Global Stem Cells Group Inc. (GSCG). GSCG operates in the global stem cell market which is forecasted by Transparency Market Research to reach $270 billion dollars by 2025 of which roughly 40% or $100 billion will be derived from outside of North America and growing at a 13.8% compounded annual growth rate. GSCG specializes in leading-edge stem cell research, patient application and physician training.